Baxter International Inc. will bolster its regenerative medicine and biosurgery offerings by acquiring Synovis Life Technologies Inc. for $325 million under a definitive agreement announced Dec. 13.
Synovis’ biological and mechanical products for soft tissue repair will complement Baxter offerings for hemostasis, tissue sealing and adherence, the...